Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 927

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 2
Chunk 927
---
 and underwriters in an underwritten registration may exclude
some or all of the Registrable Securities from the underwritten registration if the underwriters believe that including the Registrable
Securities would adversely affect the underwritten offering.

At
any time within the 12 months closing, upon any issuance by the Company or any of its subsidiaries of debt or common stock or common
stock equivalents for cash consideration, indebtedness or a combination of units thereof, other than in an underwritten public offering
(a “Subsequent Financing”), the investor will have the right to participate up to its investment amount in the Note, but
not more than 25% of the Subsequent Financing, on the same terms, conditions and price provided for in the Subsequent Financing.

Until
the Company has consummated a Qualified Offering which results in a listing of the common stock onto a national securities exchange,
if the Company engages in any future financing transactions with a third-party investor, if the holder determines that the terms of the
subsequent investment are preferable in any respect to the terms of the securities of the Company issued to the Holder pursuant to the
terms of the Purchase Agreement, the holder will have the right to amend and restate such securities to include the preferable term or
terms.

89

Notes
Payable, related party

The
Company’s Chief Executive Officer (CEO) has loaned the Company working capital since inception. The balance of the loans to the
CEO as of December 31, 2024 and 2023 was $146,432 and $358,479, respectively. The loan is due on demand and accrues interest at 3% per
year. Accrued interest relating to the loan was $1,064 and $11,308 as of December 31, 2024 and 2023, respectively, and is included in
accrued interest on the accompanying balance sheets. The Company repaid a total of $100,000 during the year ended December 31, 2024,
$83,880 in principal and $16,120 in accrued interest.

During
the year ended December 31, 2023, an employee loaned the Company $25,000. The balance of the loan as of December 31, 2024 and 2023, was
$0 and $25,000, respectively. The loan is due on demand and accrues interest at 3% per year. Accrued interest related to the loan was
$0 and $